Genomic Medicine: Is The Platform The FDA Product ...
Gene therapy platforms are improving at a rapid pace, becoming reliable products leveraged across entire pipelines. The FDA has recognized that for gene therapies the product component mix increased from 20% to 80%. With 80% of a therapy candidate tied to the platform, any effort by the FDA to ...
